Epilepsy medication - Valproate update

The medicines regulator (MHRA) has announced further changes to prescribing the epilepsy medication valproate which are due to be introduced over the coming months.

If you, or your child, take valproate, you do not need to do anything at this time and you should continue taking the medication as prescribed.

Further information from MHRA regarding the new measures is awaited and we will update our website when this is available.

We understand the proposed changes are due to start in 2023 and will gradually be phased in over several months and no changes are advised at present.

However, it is very important that you continue to take your medication as prescribed, unless advised otherwise by your doctor, as this helps provide protection against the harm of seizures.

Valproate is also known as Epilim, Depakote, Convulex, Episenta, Epival, Kentlim, Orlept, Sodium Valproate, Syonell, Valpal, Belvo and Dyzantil.

New valproate measures